Medical Director, Clinical Development – MRD Portfolio (Solid Tumors)

Labcorp is a global leader in laboratory services, providing the insights and answers that help healthcare providers, patients, researchers, pharmaceutical companies and health systems make confident decisions and improve outcomes. Through our unparalleled science, data, technology and laboratory network, we advance diagnostics, accelerate innovation and help address some of the world’s most important health challenges. As we shape the future of healthcare, we are leveraging advanced technologies, intelligent digital solutions and data-driven innovation across our operations to enhance how work gets done and deliver greater value to customers and patients. With our global scale and deep expertise, you’ll have the opportunity to do meaningful work, grow your career and make a real impact on people’s health around the world. Together, we’re improving health and improving lives. Labcorp Oncology is seeking a Medical Director, Clinical Development - MRD Portfolio (Solid Tumors ) to join our team! Work Schedule: Monday - Friday, 1st shift Job Summary: The Medical Director, Clinical Development – MRD Portfolio is a physician scientific leader responsible for shaping and executing the clinical development strategy for Labcorp Oncology's minimal residual disease (MRD) portfolio across solid tumors. This individual serves as the medical lead for the development, validation, and clinical adoption of MRD and circulating tumor DNA (ctDNA)-based technologies, advancing precision oncology through innovative molecular diagnostics that improve patient outcomes across the cancer care continuum. As the clinical development lead for the MRD portfolio, this role is responsible for generating the clinical evidence required to support product development, clinical validity, clinical utility, reimbursement, guideline inclusion, and integration into routine oncology practice. The Medical Director partners closely with stakeholders across research and development, operations, biostatistics, medical affairs, market access, regulatory affairs, commercial, and executive leadership to develop and execute a cohesive clinical strategy across multiple tumor types and indications. The successful candidate will be a board-certified medical oncologist with expertise in solid tumors, clinical research, and evidence generation. This individual will serve as a key scientific representative for Labcorp Oncology, collaborating with leading investigators, professional societies, cooperative groups, payers, and other external stakeholders to establish MRD testing as an integral component of personalized cancer management. Job Responsibilities: Clinical Development Leadership Serve as the clinical development lead for Labcorp Oncology's MRD portfolio across solid tumors, providing strategic medical leadership for evidence generation, product development, and clinical adoption initiatives. Develop and execute clinical development strategies supporting MRD and ctDNA-based technologies across multiple tumor types, disease settings, and clinical applications. Lead the medical design and clinical oversight of evidence-generation programs that establish the clinical validity, clinical utility, and health economic value of MRD testing. Drive alignment across internal stakeholders involved in clinical studies, evidence generation, and product development activities. Translate emerging clinical data into actionable recommendations that inform portfolio strategy, indication expansion, product development, and clinical adoption. Serve as the senior clinical subject matter expert for MRD technologies and applications across the oncology portfolio. Support investigator-initiated studies, strategic research collaborations, and real-world evidence programs that expand the evidence base supporting MRD testing. Portfolio and Product Leadership Provide medical leadership for the MRD portfolio throughout the product lifecycle, from concept development through commercialization and lifecycle management. Define clinical evidence requirements, intended use populations, clinical claims, validation strategies, and evidence-generation priorities necessary to support product adoption and clinical implementation. Partner with R&D, product, and innovation teams to guide assay development, biomarker strategies, and next-generation technology initiatives. Evaluate competitive technologies, emerging biomarkers, and evolving standards of care to inform portfolio priorities and future investment decisions. Act as the primary medical advisor for MRD-related portfolio strategy and indication expansion opportunities. Clinical Utility, Market Access, and Adoption Partner with market access teams to develop and execute evidence-generation strategies supporting payer coverage, reimbursement, and health-system adoption. Provide medical leadership for studies designed to demonstrate clinical utility, impact on physician decision-making, patient outcomes, and economic value. Support interactions with payers, policy stakeholders, and guideline organizations by communicating the clinical rationale and value proposition of MRD testing. Contribute to strategies supporting inclusion of MRD testing within clinical practice guidelines, treatment pathways, and value-based care models. Ensure clinical development priorities and evidence-generation plans align with reimbursement, market access, and adoption objectives. Investigator and External Scientific Leadership Build and maintain strategic relationships with leading oncology investigators, academic medical centers, cooperative groups, professional societies, and industry partners. Serve as the physician lead for external scientific collaborations, investigator engagement, and evidence-generation partnerships supporting MRD technologies. Influence the evolution of MRD clinical applications through engagement with key opinion leaders, scientific experts, and research organizations